Melanoma | Tumor

Cancer Vaccine for NSCLC and Melanoma Could Be Paradigm-Changing

August 8th 2024, 2:01pm

Article

The cancer vaccine, mRNA-4157, garnered immune responses of 30 weeks among some patients with melanoma and lung cancer, study results showed.

Questions Patients Should Ask After a Cancer Diagnosis

July 24th 2024, 7:00pm

Article

We asked oncology experts what questions patients should ask their doctors soon after receiving a cancer diagnosis. This is their advice.

Presurgical Targeted Therapy, Immunotherapy Show Responses in Melanoma

July 22nd 2024, 9:00pm

Article

Researchers have found that among patients with certain melanoma, presurgical targeted therapy and immunotherapy can result in better pathologic response.

Researchers Urge Caution of Immunotherapy in Older Patients with Melanoma

July 20th 2024, 2:00pm

Article

Citing toxicities and lack of efficacy, some are calling for caution when treating older patients with melanoma with immune checkpoint inhibitors.

OBX-115 Receives FDA Fast Track Designation in Advanced Melanoma

July 10th 2024, 3:00pm

Article

The TIL therapy OBX-115 ‘may have the potential to address’ an unmet need among patients with metastatic or locally advanced melanoma.

Presurgical, Postsurgical Targeted Therapy Effective in Some Melanomas

July 9th 2024, 7:00pm

Article

Perioperative treatment with BRAF and MEK inhibitors was found to benefit some patients with stage 3 and 4 melanoma, according to a recent study.

New Cancer Vaccine Shows Promise in Melanoma

July 3rd 2024, 7:00pm

Article

Following promising European trial results, a new peptide vaccine for melanoma is being studied in America, with results expected next year.

Shifting the Spotlight to Cancer Vaccines

June 23rd 2024, 6:00pm

Article

With many groundbreaking cancer therapies on the horizon, it's also time to focus on up and coming cancer vaccines.

Cancer Vaccines Are a 'Marvel'

June 18th 2024, 7:00pm

Article

Are cancer vaccines the new frontier in oncology? Experts and patients weigh in from the front lines.

Patients With Stage 3 Melanoma Should Discuss Adjuvant Therapy

June 7th 2024, 9:00pm

Video

Patients with resectable stage 3 melanoma should talk about pretreatment therapy with their cancer care teams, an expert said.